prognostic signature
Researchers Identify Five-Gene Metabolic Signature to Predict Pancreatic Cancer Patients' Survival
The study analyzed genomic and clinical data from The Cancer Genome Atlas and the Gene Expression Omnibus databases to evaluate the signature's prognostic value.
Dartmouth Spinoff Episteme Prognostics Aims to Bring Precision Epigenetics to Pancreatic Cancer
Premium
The researchers at the startup have developed a microarray test to predict patients' response to chemotherapy based on chromatin accessibility.
Agendia, Paige Partner to Codevelop New Assays Using MammaPrint, BluePrint Signatures
The companies aim to create new products enabling faster access to predictive information used in treatment planning for patients with breast cancer.
Investigators compared expression in different men across the genes from three commercial panels, arguing that the findings highlight important unknowns.
Biotech Support Group, Leiden University Medical Center Ink Cancer Biomarker Research Agreement
The group will define and quantify Stroma Liquid Biopsy biomarkers in Leiden University-collected sera to correlate them with Leiden's tumor-stroma ratio scoring methods.